|
Daniel Vapnek, PhD, is currently an adjunct professor at the University of California, Santa Barbara, and has played an influential role in biotechnology in both academics and industry. For 16 years, Dr. Vapnek was the head of research at Amgen, the world's largest biotechnology company. He joined Amgen in 1981 as the director of research when the company had 36 employees, and rose to senior vice president of research by 1988. When he retired in 1997, the company had more than 5,000 employees worldwide and revenues of $2.4 billion. While at Amgen, Dr. Vapnek worked closely with Philip Whitcome, PhD, Amgen's former director of strategic planning and also one of its first employees. Prior to joining Amgen, Dr. Vapnek held a number of positions at the University of Georgia and the Yale University School of Medicine. He was awarded both his BS (1963) and PhD (1968) by the University of Miami in Florida. | 